Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5070737
Max Phase: Preclinical
Molecular Formula: C69H93N17O18S2
Molecular Weight: 1512.74
Molecule Type: Unknown
Associated Items:
ID: ALA5070737
Max Phase: Preclinical
Molecular Formula: C69H93N17O18S2
Molecular Weight: 1512.74
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)CNC(=O)CNC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]2CSSC[C@@H](NC1=O)C(=O)N[C@H](Cc1ccccc1)C(=O)N1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N2
Standard InChI: InChI=1S/C69H93N17O18S2/c1-4-37(2)56-65(101)82-48-35-105-106-36-49(81-60(96)43(18-11-25-72-69(70)71)76-54(91)34-75-59(95)45(31-55(92)93)78-63(99)50-19-12-26-85(50)68(104)47(80-61(48)97)30-40-16-9-6-10-17-40)62(98)84-57(38(3)87)66(102)79-44(28-41-21-23-42(88)24-22-41)58(94)74-32-52(89)73-33-53(90)77-46(29-39-14-7-5-8-15-39)67(103)86-27-13-20-51(86)64(100)83-56/h5-10,14-17,21-24,37-38,43-51,56-57,87-88H,4,11-13,18-20,25-36H2,1-3H3,(H,73,89)(H,74,94)(H,75,95)(H,76,91)(H,77,90)(H,78,99)(H,79,102)(H,80,97)(H,81,96)(H,82,101)(H,83,100)(H,84,98)(H,92,93)(H4,70,71,72)/t37-,38+,43-,44-,45-,46-,47+,48+,49-,50+,51-,56-,57-/m0/s1
Standard InChI Key: RPOYSGRORHYYKN-KWQWKNATSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1512.74 | Molecular Weight (Monoisotopic): 1511.6326 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Muratspahić E, Tomašević N, Koehbach J, Duerrauer L, Hadžić S, Castro J, Schober G, Sideromenos S, Clark RJ, Brierley SM, Craik DJ, Gruber CW.. (2021) Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain., 64 (13.0): [PMID:34162205] [10.1021/acs.jmedchem.1c00158] |
Source(1):